Starting a company out of an academic lab may not be easy, but with the right idea and validated science, investors will come, says UTR Therapeutics CEO Chidiebere Awah, MD.

George Church, PhD, who leads Synthetic Biology at Harvard University's Wyss Institute and has co-founded some 50 biotech companies, shares insights about how machine learning is dramatically transforming the speed of drug development and testing.

Female-founded startups have a higher success rate but receive less than 2% of global VC funding. Melissa Wallace, co-founder of Fierce Foundry joins Tuesday Talks to discuss how female entrepreneurs can go from idea to exit. 

Serial entrepreneur and academic researcher Shana Kelley, PhD, is President of the Chan Zuckerberg Biohub Chicago and Professor of chemistry and biomedical engineering at Northwestern University. She holds 50 patents and established four startups.

Elizabeth Comen, MD, is a breast cancer oncologist and Associate Professor of Medicine at NYU Langone Health. She also is the author of All in Her Head: The Truth and Lies Early Medicine Taught Us About Women's Bodies and Why It Matters Today.

As a young radiologist in Casablanca, Morocco, Saad Slimani, MD, MS, noticed an opportunity to use AI to provide all pregnant women, regardless of socioeconomic status, with access to a simple procedure that could save their lives as well as the lives of their babies.